#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multiple system atrophy Lymphatic malformation Cholangiocarcinoma Small cell lung cancer Congenital ectodermal dysplasia Follicle centre lymphoma follicular grade I II – III refractory Diffuse large B-cell lymphoma refractory Langerhans' cell histiocytosis Liposarcoma Epstein-Barr virus associated lymphoproliferative disorder Pelizaeus-Merzbacher disease Congenital pseudarthrosis Primary amyloidosis Cutaneous T-cell lymphoma recurrent Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Osteosarcoma – Basic Information Myxofibrosarcoma – Life with Disease Haemophilia A with anti factor VIII – Basic Information Acute respiratory distress syndrome Gaucher’s disease type III – Life with Disease Medulloblastoma recurrent – Basic Information Cerebral arteriovenous malformation haemorrhagic – Treatment Alport’s syndrome CADASIL – Trials in Disease Epidermolysis bullosa More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nitrous Oxide Azd8421 Sevoflurane Bupivacaine Biotin MORPHINE Fingolimod Hydrochloride Elinzanetant FRUQUINTINIB Ponatinib Naloxone Hydrochloride STREPTOCOCCUS VIRIDANS Spartalizumab Fampridine Streptococcus Pneumoniae Dexketoprofen Mercaptopurine Monohydrate Dasiglucagon Apadamtase Alfa Defactinib More therapies…

    Learn about Your Condition

    Hepatic encephalopathy Behcet's syndrome Brain abscess Uterine cancer Large cell lung cancer Keratosis follicular Pulmonary hypertension Complex regional pain syndrome Urinary incontinence Wolfram syndrome Gastrointestinal carcinoma Rectal adenocarcinoma Acute HIV infection Rectal cancer stage II Melanoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kindernierenzentrum Bonn

Kindernierenzentrum Bonn

Im Muehlenbach 2b, Lengsdorf, Bonn, 53127, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effects of ABO-101 with mRNA-002 and gRNA-001 for Patients with Primary Hyperoxaluria Type 1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Primary hyperoxaluria
    Investigated Drugs:
    • GRNA-001
    France Germany The Netherlands

  • Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Proteinuria
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrogenic anaemia
    Investigated Drugs:
    • Epoetin Alfa
    • Methoxy Polyethylene Glycol-Epoetin Beta
    • Roxadustat
    Belgium Bulgaria Croatia Czechia Denmark Finland +14

  • Study of nedosiran for patients with primary hyperoxaluria type 1 and severe kidney impairment with or without dialysis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Nedosiran
    Germany Italy Spain

  • Long-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperoxaluria
    Investigated Drugs:
    • Nedosiran
    France Germany Italy The Netherlands Norway Spain

  • Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    • Proteinuria
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!